Clene Inc. to Showcase Neurodegenerative Disease Breakthroughs at Investor Summit
June 9, 2025 — Clene Inc. (NASDAQ: CLNN) announces CEO Rob Etherington's presentation at Investor Summit Virtual, showcasing progress in neurodegenerative disease treatments. Learn more about their innovative therapy, CNM-Au8®.